Jonathan Sporn

Fondatore presso Gilgamesh Pharmaceuticals, Inc.

Health Services

Health Technology

Profilo

Jonathan Sporn is the founder of Perception Neuroscience, Inc. and Gilgamesh Pharmaceuticals, Inc. At Perception Neuroscience, he holds no specific title.
At Gilgamesh Pharmaceuticals, he held the titles of President, Chief Executive Officer, and Director, but is no longer active in those roles.

Posizioni attive di Jonathan Sporn

Società	Posizione	Inizio
Gilgamesh Pharmaceuticals, Inc. Gilgamesh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gilgamesh Pharmaceuticals, Inc. engages in the development of drugs for the treatment of neuropsychiatric conditions including depression, anxiety, substance use, and stress-related disorders. Its products pipeline include Arylcyclohexylamine, Serotonergic Micro-Dose, and Novel Ibogaine Analogue. The company was founded by Jonathan Sporn, Dalibor Sames, Andrew Kruegel, Jeff Witkin, and Mike Cunningham and is headquartered in New York, NY.	Fondatore	-

Tutte le posizioni attive di Jonathan Sporn

Precedenti posizioni note di Jonathan Sporn

Società	Posizione	Fine
Perception Neuroscience, Inc. Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY.	Fondatore	-

Vedi nel dettaglio l'esperienza di Jonathan Sporn

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jonathan Sporn

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Perception Neuroscience, Inc. Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY.	Health Services
Gilgamesh Pharmaceuticals, Inc. Gilgamesh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gilgamesh Pharmaceuticals, Inc. engages in the development of drugs for the treatment of neuropsychiatric conditions including depression, anxiety, substance use, and stress-related disorders. Its products pipeline include Arylcyclohexylamine, Serotonergic Micro-Dose, and Novel Ibogaine Analogue. The company was founded by Jonathan Sporn, Dalibor Sames, Andrew Kruegel, Jeff Witkin, and Mike Cunningham and is headquartered in New York, NY.	Health Technology